http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111701580-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2202-0413 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-3679 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-3621 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J20-265 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M1-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01J20-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01J20-26 |
| filingDate | 2020-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-111701580-B |
| titleOfInvention | Middle molecular toxin adsorbent for removing beta 2 microglobulin in blood |
| abstract | The invention relates to a medium molecular toxin adsorbent mainly comprising beta 2 microglobulin for removing blood. The polypeptide ligand comprises a carrier and a linear polypeptide ligand grafted on the carrier, wherein the linear polypeptide ligand is selected from one or more than one of KD-10, KE-10 and KE-11 polypeptide sequences. The medium molecular toxin adsorbent for removing beta 2 microglobulin mainly in blood provided by the invention has high adsorption performance on beta 2-MG, and also has certain removal on parathyroid hormone (PTH), homocysteine (Hcy), advanced glycosylation products (AGEs) and cystatin A (Cys-c). And has little effect on albumin and total protein. |
| priorityDate | 2019-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 104.